Luigi Di Lauro

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Procedures

Chemicals & Drugs

Disorders

Concepts & Ideas

Activities & Behaviors

Drug Evaluation

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Vici Patrizia; Giotta Francesco; DI Lauro Luigi; Brandi Mario; Gebbia Vittorio; Foggi Paolo; Lorusso Vito; Vitucci Carlo; Sergi Domenico; Fattoruso Silvia Ileana; Giannarelli Diana; Viola Giuditta; Corsetti Serena; Colucci Giuseppe; Lopez Massimo
Multicenter phase II trial of first-line docetaxel/gemcitabine in advanced breast cancer pretreated with adjuvant anthracyclines.
Filippetti M; Visca P; Bordignon V; Sergi D; Marolla P; Ferretti G; Tonachella R; Corzani F; Fattoruso S I; Di Lauro L
[Fiberoptic bronchoscopy as diagnostic tool in primitive lung cancer]
Vici P; Viola G; Rossi S; Botti C; Vitucci C; Sergi D; Ferranti F R; Saracca E; Di Lauro L; Corsetti S; Foggi P; Fattoruso S I S; Lopez M
Optimal sequence of anthracyclines and taxanes as adjuvant breast cancer treatment.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Luigi Di Lauro (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Vici Patrizia; Giotta Francesco; DI Lauro Luigi; Brandi Mario; Gebbia Vittorio; Foggi Paolo; Lorusso Vito; Vitucci Carlo; Sergi Domenico; Fattoruso Silvia Ileana; Giannarelli Diana; Viola Giuditta; Corsetti Serena; Colucci Giuseppe; Lopez Massimo
Multicenter phase II trial of first-line docetaxel/gemcitabine in advanced breast cancer pretreated with adjuvant anthracyclines.
Anticancer research 2009;29(5):1841-5.
2009: Filippetti M; Visca P; Bordignon V; Sergi D; Marolla P; Ferretti G; Tonachella R; Corzani F; Fattoruso S I; Di Lauro L
[Fiberoptic bronchoscopy as diagnostic tool in primitive lung cancer]
La Clinica terapeutica 2009;160(1):43-6.
2008: Vici P; Viola G; Rossi S; Botti C; Vitucci C; Sergi D; Ferranti F R; Saracca E; Di Lauro L; Corsetti S; Foggi P; Fattoruso S I S; Lopez M
Optimal sequence of anthracyclines and taxanes as adjuvant breast cancer treatment.
La Clinica terapeutica 2008;159(6):453-6.
2008: Vici P; Viola G; Botti C; Rossi S; Vitucci C; Corsetti S; Di Lauro L; Sergi D; Foggi P; Perri P; Tirelli C; Mottolese M; Fattoruso S I S; Lopez M
Docetaxel in the adjuvant therapy of HER-2 positive breast cancer patients.
La Clinica terapeutica 2008;159(6):449-52.
2008: Fattoruso S I S; Rossi S; Vici P; Di Filippo F; Botti C; Di Lauro L; Foggi P; Saracca E; Ferranti F R; Visca P; Lopez M
[Optimal role of docetaxel in adjuvant chemotherapy for early stage HER2-negative breast cancer]
La Clinica terapeutica 2008;159(6):443-7.
2008: Fattoruso S I S; Rossi S; Di Lauro L; Botti C; Vici P; Lopez M
[Development of docetaxel in the adjuvant chemotherapy of breast cancer]
La Clinica terapeutica 2008;159(5):369-76.
2008: Vici Patrizia; Di Lauro Luigi; Sergi Domenico; Foggi Paolo; Viola Giuditta; Mottolese Marcella; Giotta Francesco; Fattoruso Silvia I S; Corsetti Serena; Giannarelli Diana; Botti Claudio; Lopez Massimo
A phase II trial of docetaxel and vinorelbine in patients with advanced breast cancer previously treated with anthracyclines.
Oncology 2008;75(3-4):175-81.
2007: Di Lauro L; Nunziata C; Arena M G; Foggi P; Sperduti I; Lopez M
Irinotecan, docetaxel and oxaliplatin combination in metastatic gastric or gastroesophageal junction adenocarcinoma.
British journal of cancer 2007;97(5):593-7.
2007: Conti F; Carpano S; Sergi D; Di Lauro L; Amodio A; Vici P; Abbate M I; Ferranti F R; Viola G; Botti C; Foggi P; Sperduti I; Lopez M
[High-dose CEF (cyclophosphamide, epirubicin, fluorouracil) as primary chemotherapy in locally advanced breast cancer: long-term results]
La Clinica terapeutica 2007;158(4):331-41.
2006: Papaldo Paola; Ferretti Gianluigi; Di Cosimo Serena; Giannarelli Diana; Marolla Paolo; Lopez Massimo; Cortesi Enrico; Antimi Mauro; Terzoli Edmondo; Carlini Paolo; Vici Patrizia; Botti Claudio; Di Lauro Luigi; Naso Giuseppe; Nisticò Cecilia; Mottolese Marcella; Di Filippo Franco; Ruggeri Enzo Maria; Ceribelli Anna; Cognetti Francesco
Does granulocyte colony-stimulating factor worsen anemia in early breast cancer patients treated with epirubicin and cyclophosphamide?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(19):3048-55.
2005: Papaldo Paola; Lopez Massimo; Marolla Paolo; Cortesi Enrico; Antimi Mauro; Terzoli Edmondo; Vici Patrizia; Barone Carlo; Ferretti Gianluigi; Di Cosimo Serena; Carlini Paolo; Nisticò Cecilia; Conti Francesca; Di Lauro Luigi; Botti Claudio; Di Filippo Franco; Fabi Alessandra; Giannarelli Diana; Calabresi Federico
Impact of five prophylactic filgrastim schedules on hematologic toxicity in early breast cancer patients treated with epirubicin and cyclophosphamide.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(28):6908-18.
2005: Di Lauro L; Belli F; Arena M G; Carpano S; Paoletti G; Giannarelli D; Lopez M
Epirubicin, cisplatin and docetaxel combination therapy for metastatic gastric cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(9):1498-502.
2005: Vici Patrizia; Foggi Paolo; Colucci Giuseppe; Capomolla Elisabetta; Brandi Mario; Giotta Francesco; Gebbia Nicola; Di Lauro Luigi; Valerio Maria Rosaria; Paoletti Giancarlo; Belli Franca; Pizza Carmine; Giannarelli Diana; Lopez Massimo
Sequential docetaxel followed by epirubicin-vinorelbine as first-line chemotherapy in advanced breast cancer.
Anticancer research 2005;25(2B):1309-14.
2003: Papaldo Paola; Lopez Massimo; Cortesi Enrico; Cammilluzzi Eugenio; Antimi Mauro; Terzoli Edmondo; Lepidini Giuseppe; Vici Patrizia; Barone Carlo; Ferretti Gianluigi; Di Cosimo Serena; Nistico Cecilia; Carlini Paolo; Conti Francesca; Di Lauro Luigi; Botti Claudio; Vitucci Carlo; Fabi Alessandra; Giannarelli Diana; Marolla Paolo
Addition of either lonidamine or granulocyte colony-stimulating factor does not improve survival in early breast cancer patients treated with high-dose epirubicin and cyclophosphamide.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(18):3462-8.
2002: Lopez Massimo; Vici Patrizia; Di Lauro Luigi; Carpano Silvia
Increasing single epirubicin doses in advanced soft tissue sarcomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(5):1329-34.
2001: Vici P; Belli F; Di Lauro L; Amodio A; Conti F; Foggi P; Gionfra T; Morelli M F; Botti C; Ferraironi A; Lopez M
Docetaxel in patients with anthracycline-resistant advanced breast cancer.
Oncology 2001;60(1):60-5.
2000: Vici P; Amodio A; Di Lauro L; Conti F; Gionfra T; Belli F; Lopez M
First-line chemotherapy with vinorelbine and paclitaxel as simultaneous infusion in advanced breast cancer.
Oncology 2000;58(1):3-7.
1999: Cavaliere F; Di Filippo F; Cosimelli M; Aloe L; Arcuri E; Anzà M; Callopoli A; Di Lauro L; Morace E; Botti C; Natoli S; Tedesco M; Giunta S; Cavaliere R
The integrated treatment of peritoneal carcinomatosis. A preliminary experience.
Journal of experimental & clinical cancer research : CR 1999;18(2):151-8.
1999: Belli F; Di Lauro L; Zappanico A; Giunta S
[Docetaxel in the treatment of metastatic carcinoma of the salivary glands: report of a case]
La Clinica terapeutica 1999;150(1):77-9.
1999: Amodio A; Carpano S; Manfredi C; Del Monte G; Di Lauro L; Gionfra T; Conti F; Paoletti G; Lopez M
[Gemcitabine in advanced stage soft tissue sarcoma: a phase II study]
La Clinica terapeutica 1999;150(1):17-20.
1998: Paoletti G; Di Lauro L; Gionfra T; Venturo I; Belli F; Squilloni E; Mariotti S; Fioretti G; Gemini M; Tersigni R; Lopez M
[Sequential therapy with methotrexate and 5-fluorouracil in patients with advanced colorectal cancer pretreated with 5-fluorouracil plus folinic acid]
La Clinica terapeutica 1998;149(2):105-8.
1998: Vici P; Ferraironi A; Di Lauro L; Carpano S; Conti F; Belli F; Paoletti G; Maini C L; Lopez M
Dexrazoxane cardioprotection in advanced breast cancer patients undergoing high-dose epirubicin treatment.
La Clinica terapeutica 1998;149(921):15-20.
1998: Palmeri S; Meli M; Danova M; Bernardo G; Leonardi V; Dastoli G; Rausa L; Russo A; Filippelli G; Palmieri G; Russo A; Della Vittoria Scarpati M; Lo Russo V; Di Lauro L; Colucci G; Bruni G; Piazzi M; Gebbia N; Spada S
5-Fluorouracil plus interferon alpha-2a compared to 5-fluorouracil alone in the treatment of advanced colon carcinoma: a multicentric randomized study.
Journal of cancer research and clinical oncology 1998;124(3-4):191-8.
1997: Casali A; Santini S; Della Giulia M; Di Lauro L; Vici P; Gionfra T; Sega F M
Triple combination antimicrobial regimen in the treatment of infections of neutropenic cancer patients.
Journal of experimental & clinical cancer research : CR 1997;16(3):321-4.
1997: Vici P; Di Lauro L; Conti F; Capomolla E; Gionfra T; Amodio A; Lopez M
Paclitaxel activity in anthracycline refractory breast cancer patients.
Tumori 1997;83(3):661-4.
1996: Vici P; Di Lauro L; Carpano S; Amodio A; Pignatti F; Casali A; Conti F; Lopez M
Vinorelbine and mitomycin C in anthracycline-pretreated patients with advanced breast cancer.
Oncology 1996;53(1):16-8.
1995: Lopez M; Di Lauro L; Paoletti G; Santini S; Gandolfo G M; Vitelli G; Frasca A M; Ameglio F; Rasi G; Garaci E
Sequential biochemotherapy for metastatic colorectal cancer using fluorouracil, folinic acid, thymopentin and interleukin-2: clinical and immunological effects.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1995;6(10):1011-7.
1995: Lopez M; Vici P; Di Lauro L; Paoletti G; Gionfra T; Conti F; Carpano S; Pignatti F; Giannarelli D
Intrapatient comparison of single-agent epirubicin with or without lonidamine in metastatic breast cancer.
European journal of cancer (Oxford, England : 1990) 1995;31A(10):1611-4.
1995: Di Lauro L; Del Medico P; Carpano S; Cancrini A; Gionfra T; Vici P; Rosselli M; Lopez M
Sequential subcutaneous thymopentin, interferon alpha-2a and interleukin-2 in metastatic renal cell cancer.
Tumori 1995;81(1):42-4.
1994: Lopez M; Carpano S; Cavaliere R; Di Lauro L; Ameglio F; Vitelli G; Frasca A M; Vici P; Pignatti F; Rosselli M
Biochemotherapy with thymosin alpha 1, interleukin-2 and dacarbazine in patients with metastatic melanoma: clinical and immunological effects.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(8):741-6.
1993: Lopez M; Carpano S; Cancrini A; Marcellini M; Del Medico P; Rinaldi M; Vici P; Paoletti G; Di Lauro L
Phase II study of continuous intravenous infusion of recombinant interleukin-2 in patients with advanced renal cell carcinoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1993;4(8):689-91.
1993: Lopez M; Natali M; Di Lauro L; Vici P; Pignatti F; Carpano S
Combined treatment with buserelin and cyproterone acetate in metastatic male breast cancer.
Cancer 1993;72(2):502-5.
1991: Calabresi F; Di Lauro L; Marolla P; Curcio C G; Paoletti G; Calabró A; Giannarelli D; Ballatore P; Foggi C M; Di Palma M
Fluorouracil, doxorubicin, and cyclophosphamide versus fluorouracil, doxorubicin, and cyclophosphamide plus lonidamine for the treatment of advanced breast cancer: a multicentric randomized clinical study.
Seminars in oncology 1991;18(2 Suppl 4):66-72.
1991: Vici P; Veltri E; Carpano S; Di Lauro L; Lopez M
[Buserelin therapy in postmenopausal patients with advanced breast carcinoma]
La Clinica terapeutica 1991;136(3):195-9.
1991: Lopez M; Carpano S; Di Lauro L; Vici P; Conti E M
Epirubicin and DTIC (EDIC) for advanced soft-tissue sarcomas.
Oncology 1991;48(3):230-3.
1991: Lopez M; Vici P; Carpano S; Natali M; Ganzina F; Conti E M; Di Lauro L
Combination chemotherapy with oral idarubicin and cyclophosphamide for metastatic breast cancer.
Journal of cancer research and clinical oncology 1991;117(1):61-4.
1991: Lopez M; Di Lauro L; Gionfra T; Gandolfo G; Ameglio F; Paoletti G
Thymopentin and interleukin-2 in combination with 5-fluorouracil and leucovorin in metastatic colorectal adenocarcinoma: preliminary results.
Journal of surgical oncology. Supplement 1991;2():108-11.
1990: Lopez M; Natali M; Di Lauro L; Tonini G; Carpano S; Vici P; Conti E M
5-Fluorouracil, epirubicin, and BCNU (FEB) in advanced measurable gastric cancer.
American journal of clinical oncology 1990;13(3):204-7.
1989: Lopez M; Contegiacomo A; Vici P; Dello Ioio C; Di Lauro L; Pagliarulo C; Carpano S; Giannarelli D; De Placido S; Fazio S
A prospective randomized trial of doxorubicin versus idarubicin in the treatment of advanced breast cancer.
Cancer 1989;64(12):2431-6.
1989: Lopez M; Papaldo P; Di Lauro L; Vici P; Carpano S; Conti E M
5-Fluorouracil, adriamycin, cyclophosphamide (FAC) vs. 5-fluorouracil, epirubicin, cyclophosphamide (FEC) in metastatic breast cancer.
Oncology 1989;46(1):1-5.
1987: Lopez M; Carassai A; Di Lauro L; Mignano M; Papaldo P; Vici P; Carpano S; Balice A; Di Gaetano G
[Colorectal carcinoma. II. Adjuvant therapy]
La Clinica terapeutica 1987;121(1):15-27.
1987: Lopez M; Carassai A; Di Lauro L; Papaldo P; Carpano S; Vici P; Mignano M; Di Gaetano G
[Colorectal cancer. I. Chemotherapy in the advanced stage]
La Clinica terapeutica 1987;120(6):473-87.
1986: Lopez M; Di Lauro L; Papaldo P; Ganzina F; Di Pietro N; Lazzaro B
Phase II evaluation of oral idarubicin (4-demethoxydaunorubicin) in patients with disseminated malignant melanoma.
Cancer treatment reports 1986;70(7):911-2.
1986: Lopez M; Vici P; Balice A; Carpano S; Papaldo P; Di Lauro L
[Current status of osteosarcoma therapy]
La Clinica terapeutica 1986;117(5):409-25.
1986: Lopez M; Vici P; Carpano S; Balice A; Di Lauro L; Papaldo P
[Ewing's sarcoma: current status of its therapy]
La Clinica terapeutica 1986;116(5):403-13.
1986: Lopez M; Di Lauro L; Papaldo P; Conti E M
Treatment of advanced measurable gastric carcinoma with 5-fluorouracil, adriamycin, and BCNU.
Oncology 1986;43(5):288-91.
1986: Lopez M; Di Lauro L; Papaldo P
Oral idarubicin in non-Hodgkin's lymphomas.
Investigational new drugs 1986;4(3):263-7.
1986: Lopez M; Di Lauro L; Papaldo P; Lazzaro B; Ganzina F; Di Pietro N
Phase II trial with oral idarubicin in advanced breast cancer.
Investigational new drugs 1986;4(1):39-42.
1985: Di Lauro L; Balice A; Carpano S; Papaldo P; Lopez M
[Mitomycin C and cisplatin as single agents in the second-line treatment of advanced gastric cancer]
La Clinica terapeutica 1985;115(5):361-4.
1985: Di Lauro L; Balice A; Papaldo P; Lopez M
[Mitomycin C in the treatment of sarcomas of the soft tissues in the adult in an advanced phase]
La Clinica terapeutica 1985;115(2):83-5.
1985: Lopez M; Perno C F; Di Lauro L; Papaldo P; Ganzina F; Di Pietro N
Epirubicin in non-Hodgkin's lymphomas.
American journal of clinical oncology 1985;8(2):151-3.
1985: Lopez M; Di Lauro L; Papaldo P; Lazzaro B
Chemotherapy in metastatic male breast cancer.
Oncology 1985;42(4):205-9.
1985: Lopez M; Di Lauro L; Lazzaro B; Papaldo P
Hormonal treatment of disseminated male breast cancer.
Oncology 1985;42(6):345-9.
1984: Lopez M; Di Lauro L; Papaldo P; Perno C F
Alternating combination chemotherapy of advanced soft tissue sarcomas in adults.
American journal of clinical oncology 1984;7(5):539-42.
1984: Lopez M; Di Lauro L; Papaldo P; Lazzaro B
[Therapeutic activity of epirubicin in malignant melanoma and non-Hodgkin's lymphoma]
La Clinica terapeutica 1984;109(1):31-5.
1984: Barduagni A; Barduagni M; Di Lauro L; Nardi M; Gallo Curcio C; Tonachella R; Ciottoli G B; Delle Chiaie S
Early observations on the administration of Lonidamine in cancer patients.
Oncology 1984;41 Suppl 1():78-81.
1984: Lopez M; Perno C F; Papaldo P; Di Lauro L; Ganzina F; Barduagni A
Phase II study of epirubicin in advanced malignant melanoma.
Investigational new drugs 1984;2(3):315-7.
1984: Lopez M; Perno C F; Di Lauro L; Papaldo P; Ganzina F; Barduagni A
Controlled study of DTIC versus DTIC plus epirubicin in metastatic malignant melanoma.
Investigational new drugs 1984;2(3):319-22.
1984: Lopez M; Perno C F; Di Lauro L; Papaldo P
5-fluorouracil, adriamycin, and BCNU (FAB) combination chemotherapy for advanced gastric cancer.
Cancer chemotherapy and pharmacology 1984;12(3):194-7.
1983: Lopez M; Di Lauro L; Perno C F; Papaldo P; Barduagni M; Barduagni A
5-Fluorouracil, adriamycin and cyclophosphamide combined with high-dose medroxyprogesterone acetate in advanced breast cancer.
Tumori 1983;69(6):545-51.
1983: Lopez M; Papaldo P; Perno C F; Di Lauro L; Barduagni A
[Toxicity of cisplatin administered with hydration of 1-hour duration and forced diuresis]
La Clinica terapeutica 1983;107(3):207-13.
1983: Lopez M; Papaldo P; Di Lauro L; Barduagni M; Perno C F; Barduagni A
Mitomycin C in patients with metastatic breast cancer refractory to hormone therapy and chemotherapy.
Oncology 1983;40(4):244-7.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Luigi Di Lauro

Research Profile (preview)

Procedures

Chemicals & Drugs

Disorders

Concepts & Ideas

Activities & Behaviors

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Luigi Di Lauro (preview)

All Publications